HLS Therapeutics Inc (OTCPK:HLTRF)
$ 2.34 0 (0%) Market Cap: 75.01 Mil Enterprise Value: 125.56 Mil PE Ratio: 0 PB Ratio: 0.90 GF Score: 54/100

HLS Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 19, 2020 / 02:00PM GMT
Release Date Price: $13.15
Operator

Good morning, and welcome to the Annual Meeting for HLS Therapeutics taking place here today, June 19 at 10 a.m. Eastern Daylight Time. (Operator Instructions) I would now like to turn the call over to Mr. Ryan Lennox, General Counsel and Corporate Secretary. Please go ahead, sir.

Ryan C. Lennox
HLS Therapeutics Inc. - General Counsel & Corporate Secretary

Thank you, operator, and thank you to everyone for your attendance today. Good morning. My name is Ryan Lennox, and I'm the General Counsel and Corporate Secretary of HLS Therapeutics, Inc.

I would like to briefly read the following forward-looking information statement before turning the meeting over to Greg Gubitz, the Chief Executive Officer.

In the course of today's meeting, directors and officers of HLS may, in their remarks or in response to questions, make certain statements that are forward-looking statements and our perspective. Forward-looking statements are neither promises nor guarantees, but are subject to risks and uncertainties that may cause the actual results,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot